Merck Outlines Strategic Shift Toward Clinical Trial Simplification and AI Integration
At the 2026 SCOPE Summit, Dr. Eliav Barr, Head of Global Clinical Development and Chief Medical Officer at Merck...
At the 2026 SCOPE Summit, Dr. Eliav Barr, Head of Global Clinical Development and Chief Medical Officer at Merck...
The 2025 Veeva Clinical Operations Oversight Forum in Copenhagen brought together sponsors, CROs, and technology partners to examine one...
At the 2025 Indegene Digital Summit, a session hosted by Indegene and Datavant, senior leaders Mayank Rizada and Melissa...
At SCOPE Europe 2025, experts underscored that the revised International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guideline,...
At the 2025 Indegene Digital Summit, a high-level panel of regulatory executives from Pfizer, Novartis, and Boehringer Ingelheim gathered...
At the SCOPE 2025 Europe conference, during a panel titled, “Trials Are Leaving Europe — Can We Bring Them...
At a landmark FDA workshop on artificial intelligence (AI) in drug development, regulators and industry leaders outlined a vision...
At a recent industry panel at SCOPE Europe, experts from advocacy organizations and pharmaceutical companies explored a striking imbalance:...
At the 2025 SCOPE Europe conference, industry leaders examined how artificial intelligence (AI) is reshaping feasibility assessment and patient...
At SCOPE Europe 2025, we spoke with Dominique Demolle, CEO of Cognivia, about how behavioral AI is helping sponsors...